End-of-day quote
Other stock markets
|
||
- USD | - |
|
2015 | Hospira : Pfizer wins EU approval for $15 billion Hospira buy | RE |
2015 | Allergan : Mylan independence from Teva's embrace comes with a price | RE |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Angela Hwang
PSD | President | 58 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 172,934,361 | 171,865,361 ( 99.38 %) | 0 | 99.38 % |
Company contact information
![address Hospira, Inc.](https://cdn.zonebourse.com/static/address/12987.png)
Group companies
Name | Category and Sector |
---|---|
Hospira UK Ltd.
![]() Hospira UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Hospira UK Ltd. is a pharmaceutical company that manufactures and markets pharmaceutical products. The company is based in Maidenhead, UK and was founded in 1985. |
Pharmaceuticals: Major
|
Sector
1st Jan change | Capi. | |
---|---|---|
+25.24% | 45.32B | |
+34.85% | 24.51B | |
+29.56% | 16.85B | |
+21.32% | 14.62B | |
+70.51% | 14.16B | |
-0.05% | 6.79B | |
+15.74% | 5.82B | |
-8.87% | 5.73B | |
+10.29% | 4.93B |
- Stock Market
- Equities
- Stock
- Company Hospira, Inc.